Subscribe
FDA’s Welch on DSHEA 2.0: ‘We have an opportunity for real, common sense reform that I don’t believe we can let pass by’
By Stephen Daniells
“FDA is not looking to throw out DSHEA and start fresh – rather we are talking about building on the current framework,” said FDA’s Dr Cara Welch. Done correctly, initiatives like a mandatory product listing would not impose significant burdens on the industry, she said.
Speaking as part of the online AHPA Botanical Congress on May 24, Dr Cara Welch, PhD, acting director of the Office of Dietary Supplement Programs (ODSP), said:
“With mandatory product listing, we believe it’s possible to construct a narrowly-tailored requirement that respects and preserves DSHEA’s original vision of consumers’ right to access safe, well-manufactured, and appropriately labeled dietary supplements with, just as important, upholding FDA’s ability to protect the public from unsafe and unlawful products.